French pharmaceutical and healthcare company Sanofi on Friday announced a share buyback plan worth up to €2 billion ($2.08 ...

The modular sterile filling system reportedly can deliver 500 to 50,000 units per batch specifically tailored for process development.

Vaxxas, a clinical-stage biotechnology company, has announced the appointments of three globally respected vaccine experts as ...

Syringes and Needles MarketThe sales of syringes and needles in the Gulf Cooperation Council (GCC) region are expected to witness steady growth, with a projected compound annual growth rate (CAGR) of ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The Global Smart Syringes Market size is expected to be worth around USD 23.9 billion by 2033 from USD 8.9 billion in 2023, growing at a CAGR of 10.4% ...

The Ministry of Health (MoH) has introduced the pneumococcal conjugate vaccine (PCV) into Brunei Darussalam’s Expanded Programme on Immunisation, effective FeB 1 as part of efforts to protect infants ...

A team from UNIGE, the Max Planck Institute for Molecular Physiology in Dortmund, and Heinrich Heine University in Düsseldorf ...

Uganda on Monday started the first-ever vaccination trial for the Sudan species of the Ebola virus four days after an ...

Uganda started a vaccination trial on Monday for the Ebola Sudan virus four days after an outbreak was confirmed, the WHO ...

The FDA will review a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).

French pharmaceutical company Sanofi said on Monday that it plans to buy back shares from cosmetics firm L'Oréal. Sanofi said ...